{"id":"https://openalex.org/W7148944459","doi":"https://doi.org/10.1158/1538-7445.am2026-5239","title":"Abstract 5239: Biomarker dynamics in the completed phase I study of DT-9081: An analysis of ex vivo cytokine stimulation, urinary PGEM, and tumoral biomarkers in advanced solid tumors","display_name":"Abstract 5239: Biomarker dynamics in the completed phase I study of DT-9081: An analysis of ex vivo cytokine stimulation, urinary PGEM, and tumoral biomarkers in advanced solid tumors","publication_year":2026,"publication_date":"2026-04-03","ids":{"openalex":"https://openalex.org/W7148944459","doi":"https://doi.org/10.1158/1538-7445.am2026-5239"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2026-5239","doi":"https://doi.org/10.1158/1538-7445.am2026-5239","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-5239","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025358774","display_name":"Thomas Maurin","orcid":"https://orcid.org/0000-0002-8467-3135","observed_orcids":["https://orcid.org/0000-0002-8467-3135"]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thomas Maurin","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008115682","display_name":"Lola Lecru","orcid":"https://orcid.org/0000-0002-2780-408X","observed_orcids":["https://orcid.org/0000-0002-2780-408X"]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lola Lecru","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091538379","display_name":"Antoine Mousson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Antoine Mousson","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059212188","display_name":"Orph\u00e9e Blanchard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Orph\u00e9e Blanchard","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017797671","display_name":"Malaury Schappler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Malaury Schappler","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063649167","display_name":"Christophe Le Tourneau","orcid":"https://orcid.org/0000-0001-9772-4686","observed_orcids":["https://orcid.org/0000-0001-9772-4686"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Le Tourneau","raw_affiliation_strings":["2Institut Gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Institut Gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091693841","display_name":"Zahra Castel Ajgal","orcid":"https://orcid.org/0000-0002-2322-9612","observed_orcids":["https://orcid.org/0000-0002-2322-9612"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Zahra Castel-Ajgal","raw_affiliation_strings":["3Institut Curie, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Institut Curie, Paris, France;","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113657266","display_name":"Jean\u2010Pascal Machiels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jean-Pascal Machiels","raw_affiliation_strings":["4Cliniques Universitaires Saint-Luc, Louvain, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Cliniques Universitaires Saint-Luc, Louvain, Belgium;","institution_ids":["https://openalex.org/I1315288073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076489661","display_name":"Rachel Galot","orcid":"https://orcid.org/0000-0002-0596-4752","observed_orcids":["https://orcid.org/0000-0002-0596-4752"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Rachel Galot","raw_affiliation_strings":["4Cliniques Universitaires Saint-Luc, Louvain, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Cliniques Universitaires Saint-Luc, Louvain, Belgium;","institution_ids":["https://openalex.org/I1315288073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030523847","display_name":"Nuria Kotecki","orcid":"https://orcid.org/0000-0002-7753-230X","observed_orcids":["https://orcid.org/0000-0002-7753-230X"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Nuria Kotecki","raw_affiliation_strings":["5Institut Jules Bordet, Bruxelles, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Institut Jules Bordet, Bruxelles, Belgium;","institution_ids":["https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089622240","display_name":"Christiane Jungels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Christiane Jungels","raw_affiliation_strings":["5Institut Jules Bordet, Bruxelles, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Institut Jules Bordet, Bruxelles, Belgium;","institution_ids":["https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028020706","display_name":"Jean\u2010Pierre Delord","orcid":"https://orcid.org/0000-0001-7305-5561","observed_orcids":["https://orcid.org/0000-0001-7305-5561"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Pierre Delord","raw_affiliation_strings":["6Institut Universiatire du Cancer de Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Institut Universiatire du Cancer de Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020724418","display_name":"Iphig\u00e9nie Korakis","orcid":"https://orcid.org/0000-0002-2112-5932","observed_orcids":["https://orcid.org/0000-0002-2112-5932"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Iphigenie Korakis","raw_affiliation_strings":["6Institut Universiatire du Cancer de Toulouse, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Institut Universiatire du Cancer de Toulouse, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015208769","display_name":"Camille Dietsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Camille Dietsch","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Luc Baron","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Luc Baron","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132845647","display_name":"Maria Jesus Garcia L\u00e9on","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maria Jesus Garcia L\u00e9on","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006008833","display_name":"Edith Steinberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Edith Steinberg","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114524586","display_name":"Katia Saulnier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Katia Saulnier","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040134869","display_name":"Samira El Farouk-Ameqrane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Samira El-Farouk","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132861910","display_name":"Calire Jouffroy-Zeller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Calire Jouffroy-Zeller","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109057985","display_name":"Anne Lise Quesnel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Quesnel","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108459770","display_name":"Carolina D. Duarte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Carolina Duarte","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065821962","display_name":"Abdelkrim Taamma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Abdelkrim Taamma","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109168099","display_name":"Anne\u2010Laure Blayo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne-Laure Blayo","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010880117","display_name":"Thibaut Brugat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thibaut Brugat","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041101215","display_name":"Nathalie Lenne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Lenne","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069419339","display_name":"Jean-Marie Cuillerot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Marie Cuillerot","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051852907","display_name":"St\u00e9phan Schann","orcid":"https://orcid.org/0000-0001-7471-491X","observed_orcids":["https://orcid.org/0000-0001-7471-491X"]},"institutions":[{"id":"https://openalex.org/I4210117585","display_name":"Domain Therapeutics (France)","ror":"https://ror.org/02gb76937","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210117585"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephan Schann","raw_affiliation_strings":["1Domain Therapeutics, Illkirch, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Domain Therapeutics, Illkirch, France;","institution_ids":["https://openalex.org/I4210117585"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"7_Supplement","first_page":"5239","last_page":"5239"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ep4-receptor-antagonist","display_name":"EP4 receptor antagonist","score":0.9750000238418579},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9800000190734863},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.925000011920929},{"id":"https://openalex.org/keywords/il-5","display_name":"IL-5","score":0.7749999761581421},{"id":"https://openalex.org/keywords/mip-1alpha","display_name":"MIP-1\u03b1","score":0.9739999771118164},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9629999995231628},{"id":"https://openalex.org/keywords/th1-response","display_name":"Th1 response","score":0.7760000228881836},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.7710000276565552},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.8144999742507935},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.7760000228881836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.699999988079071},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6208999752998352},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6165000200271606},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.5532000064849854},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5494999885559082},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.451200008392334},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.4293999969959259},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.42289999127388},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.36320000886917114},{"id":"https://openalex.org/C11988809","wikidata":"https://www.wikidata.org/wiki/Q412889","display_name":"Interleukin 6","level":3,"score":0.3483000099658966},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.33799999952316284},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33160001039505005},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.32429999113082886},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.30730000138282776},{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.3037000000476837},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2985999882221222},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.2962000072002411},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28839999437332153},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.2831999957561493},{"id":"https://openalex.org/C1621761","wikidata":"https://www.wikidata.org/wiki/Q7997549","display_name":"Whole blood","level":2,"score":0.2827000021934509},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27799999713897705},{"id":"https://openalex.org/C2777956040","wikidata":"https://www.wikidata.org/wiki/Q416554","display_name":"Prostaglandin E2","level":2,"score":0.27790001034736633},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2752000093460083}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2026-5239","doi":"https://doi.org/10.1158/1538-7445.am2026-5239","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-5239","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409688876","https://openalex.org/W4308384995","https://openalex.org/W7212947206","https://openalex.org/W3081187248","https://openalex.org/W3100570711","https://openalex.org/W4308382006","https://openalex.org/W3031516802","https://openalex.org/W2080518672","https://openalex.org/W2768002678","https://openalex.org/W4404064368"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"DT-9081,":[2],"a":[3,48,258],"novel":[4],"EP4R-antagonist,":[5],"recently":[6],"completed":[7,56,270,401],"its":[8,37,280],"Phase":[9,57,271],"I":[10,58,272,403],"study":[11,59,273,404],"in":[12,200,217,229,283,313,334,399,419],"patients":[13],"with":[14,117,206,239,319],"advanced":[15,284,420],"solid":[16,285,421],"tumors":[17,422],"(NCT05582850).":[18],"In":[19],"addition":[20],"to":[21,33,112,151],"establishing":[22],"safety,":[23],"tolerability,":[24],"and":[25,41,72,88,97,110,124,143,159,169,197,222,227,298,304,330,416],"pharmacodynamic":[26],"signals,":[27],"integrated":[28,265],"biomarker":[29,266,300],"analyses":[30,63,214],"were":[31,108,131,146,164,172,232],"conducted":[32],"gain":[34],"insights":[35,278],"into":[36,279],"mechanism":[38],"of":[39,51,60,86,120,156,188,208,220,249,274,290,309,405,409,426],"action":[40],"therapeutic":[42],"potential.":[43],"Objectives:":[44],"This":[45],"abstract":[46],"presents":[47],"comprehensive":[49],"evaluation":[50,267],"multiple":[52,310],"biomarkers":[53,418],"from":[54,106,268],"the":[55,153,209,218,269,307,314,324,400,427],"DT-9081.":[61,320],"The":[62,264,287],"include:Ex":[64],"vivo":[65,114,190,292,411],"cytokine":[66,99,115,170,191,244,293,412],"stimulation":[67],"examining":[68],"IL-10,":[69,121],"IL-5,":[70,122,195],"MIP-1\u03b1,":[71,123,196],"TNF\u03b1":[73,125],"concentrationUrinary":[74],"prostaglandin":[75,210],"E":[76],"metabolite":[77],"(tetranor-PGEM)":[78],"levels,":[79,297],"measured":[80],"by":[81,136,148,186],"LC-MS/MS":[82],"Tumor":[83,138,212],"tissue":[84,213],"expression":[85,154,219,231,301],"mPGES":[87,221],"COX2":[89,223],"enzymes,":[90],"as":[91,93,184],"well":[92],"PD-L1,":[94],"assessed":[95],"pre-":[96],"post-treatmentPlasma":[98],"levels":[100,135,155,203],"Methods:":[101],"Peripheral":[102],"blood":[103],"mononuclear":[104],"cells":[105],"subjects":[107],"isolated":[109],"subjected":[111],"ex":[113,189,291,410],"stimulation,":[116,294,413],"subsequent":[118],"quantification":[119],"using":[126],"validated":[127],"immunoassays.":[128],"Urine":[129],"samples":[130,163],"analyzed":[132],"for":[133,237,326,430],"PGEM":[134,202,296],"LC-MS/MS.":[137],"biopsies,":[139],"collected":[140,165],"at":[141,166],"baseline":[142],"after":[144,317],"treatment,":[145,226],"examined":[147],"multiplex":[149],"immunofluorescence":[150],"determine":[152],"mPGES,":[157],"COX2,":[158,303],"PD-L1.":[160],"Additionally,":[161],"plasma":[162],"serial":[167],"timepoints,":[168],"concentrations":[171],"measured.":[173],"Results:":[174],"Biomarker":[175,397],"assessments":[176],"revealed":[177],"that":[178,255],"DT-9081":[179,256,275],"treatment":[180],"modulated":[181],"immune":[182,240,261],"responses":[183],"evidenced":[185],"restauration":[187],"release":[192],"profiles":[193],"(IL-10,":[194],"TNF\u03b1).":[198],"Increase":[199],"urinary":[201,295,414],"was":[204],"consistent":[205],"modulation":[207],"pathway.":[211],"demonstrated":[215],"alterations":[216],"enzymes":[224],"following":[225],"changes":[228],"PD-L1":[230],"observed,":[233],"suggesting":[234],"potential":[235,331],"implications":[236],"combination":[238,332],"checkpoint":[241],"inhibitors.":[242],"Plasma":[243],"data":[245],"provided":[246],"additional":[247],"evidence":[248],"systemic":[250],"immunomodulation.":[251],"Integrated":[252],"analysis":[253,289,408],"suggest":[254],"favors":[257],"Th1,":[259],"antitumoral":[260],"response.":[262],"Conclusions:":[263],"offers":[276],"valuable":[277],"immunomodulatory":[281],"effects":[282],"tumors.":[286],"combined":[288],"tumor":[299],"(mPGES,":[302],"PD-L1)":[305],"supports":[306],"engagement":[308],"pathways":[311],"involved":[312],"anti-tumoral":[315],"response":[316],"treatement":[318],"These":[321],"results":[322],"lay":[323],"groundwork":[325],"further":[327],"clinical":[328],"development":[329],"strategies":[333],"immuno-oncology.":[335],"Citation":[336],"Format:":[337],"Thomas":[338],"Maurin,":[339],"Lola":[340],"Lecru,":[341],"Antoine":[342],"Mousson,":[343],"Orph\u00e9e":[344],"Blanchard,":[345],"Malaury":[346],"Schappler,":[347],"Christophe":[348],"Le":[349],"Tourneau,":[350],"Zahra":[351],"Castel-Ajgal,":[352],"Jean-Pascal":[353],"Machiels,":[354],"Rachel":[355],"Galot,":[356],"Nuria":[357],"Kotecki,":[358],"Christiane":[359],"Jungels,":[360],"Jean-Pierre":[361],"Delord,":[362],"Iphigenie":[363],"Korakis,":[364],"Camille":[365],"Dietsch,":[366],"Luc":[367],"Baron,":[368],"Maria":[369],"Jesus":[370],"Garcia":[371],"L\u00e9on,":[372],"Edith":[373],"Steinberg,":[374],"Katia":[375],"Saulnier,":[376],"Samira":[377],"El-Farouk,":[378],"Calire":[379],"Jouffroy-Zeller,":[380],"Anne":[381],"Quesnel,":[382],"Carolina":[383],"Duarte,":[384],"Abdelkrim":[385],"Taamma,":[386],"Anne-Laure":[387],"Blayo,":[388],"Thibaut":[389],"Brugat,":[390],"Nathalie":[391],"Lenne,":[392],"Jean-Marie":[393],"Cuillerot,":[394],"Stephan":[395],"Schann.":[396],"dynamics":[398],"phase":[402],"DT-9081:":[406],"An":[407],"PGEM,":[415],"tumoral":[417],"[abstract].":[423],"In:":[424],"Proceedings":[425],"American":[428],"Association":[429],"Cancer":[431,449],"Research":[432],"Annual":[433],"Meeting":[434],"2026;":[435],"Part":[436],"1":[437],"(Regular":[438],"Abstracts);":[439],"2026":[440],"Apr":[441],"17-22;":[442],"San":[443],"Diego,":[444],"CA.":[445],"Philadelphia":[446],"(PA):":[447],"AACR;":[448],"Res":[450],"2026;86(7":[451],"Suppl):Abstract":[452],"nr":[453],"5239.":[454]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-04-04T00:00:00"}